nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—melanoma	0.517	1	CbGaD
Fluticasone furoate—CYP3A4—Temozolomide—melanoma	0.141	0.376	CbGbCtD
Fluticasone furoate—ABCB1—Dactinomycin—melanoma	0.0859	0.229	CbGbCtD
Fluticasone furoate—CYP3A4—Vemurafenib—melanoma	0.0774	0.206	CbGbCtD
Fluticasone furoate—ABCB1—Docetaxel—melanoma	0.0443	0.118	CbGbCtD
Fluticasone furoate—CYP3A4—Docetaxel—melanoma	0.0266	0.0708	CbGbCtD
Fluticasone furoate—Growth retardation—Dactinomycin—melanoma	0.00687	0.0884	CcSEcCtD
Fluticasone furoate—Impaired healing—Carmustine—melanoma	0.00338	0.0434	CcSEcCtD
Fluticasone furoate—Menorrhagia—Temozolomide—melanoma	0.00191	0.0245	CcSEcCtD
Fluticasone furoate—Ulcer—Bleomycin—melanoma	0.00177	0.0227	CcSEcCtD
Fluticasone furoate—Ulcer—Dactinomycin—melanoma	0.00165	0.0212	CcSEcCtD
Fluticasone furoate—Herpes simplex—Temozolomide—melanoma	0.00153	0.0197	CcSEcCtD
Fluticasone furoate—Candida infection—Carmustine—melanoma	0.00139	0.0179	CcSEcCtD
Fluticasone furoate—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00139	0.0179	CcSEcCtD
Fluticasone furoate—Laryngeal pain—Docetaxel—melanoma	0.00138	0.0177	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Vemurafenib—melanoma	0.00136	0.0175	CcSEcCtD
Fluticasone furoate—Candida infection—Temozolomide—melanoma	0.00135	0.0173	CcSEcCtD
Fluticasone furoate—Eye disorder—Vemurafenib—melanoma	0.0013	0.0167	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Vemurafenib—melanoma	0.00125	0.0161	CcSEcCtD
Fluticasone furoate—Back pain—Vemurafenib—melanoma	0.00117	0.015	CcSEcCtD
Fluticasone furoate—Cough—Vemurafenib—melanoma	0.00105	0.0135	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Vemurafenib—melanoma	0.000985	0.0127	CcSEcCtD
Fluticasone furoate—Infection—Vemurafenib—melanoma	0.000978	0.0126	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Vemurafenib—melanoma	0.000966	0.0124	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Docetaxel—melanoma	0.000938	0.0121	CcSEcCtD
Fluticasone furoate—Candida infection—Docetaxel—melanoma	0.000896	0.0115	CcSEcCtD
Fluticasone furoate—Bronchitis—Temozolomide—melanoma	0.000851	0.011	CcSEcCtD
Fluticasone furoate—Body temperature increased—Vemurafenib—melanoma	0.000779	0.01	CcSEcCtD
Fluticasone furoate—Pharyngitis—Dactinomycin—melanoma	0.000777	0.01	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vemurafenib—melanoma	0.000726	0.00933	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Carmustine—melanoma	0.00072	0.00927	CcSEcCtD
Fluticasone furoate—Visual disturbance—Docetaxel—melanoma	0.000719	0.00924	CcSEcCtD
Fluticasone furoate—Visual impairment—Carmustine—melanoma	0.000707	0.00909	CcSEcCtD
Fluticasone furoate—Pharyngitis—Temozolomide—melanoma	0.000703	0.00905	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Temozolomide—melanoma	0.000696	0.00896	CcSEcCtD
Fluticasone furoate—Eye disorder—Carmustine—melanoma	0.000685	0.00881	CcSEcCtD
Fluticasone furoate—Visual impairment—Temozolomide—melanoma	0.000683	0.00878	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vemurafenib—melanoma	0.000674	0.00867	CcSEcCtD
Fluticasone furoate—Migraine—Docetaxel—melanoma	0.00067	0.00862	CcSEcCtD
Fluticasone furoate—Eye disorder—Temozolomide—melanoma	0.000662	0.00852	CcSEcCtD
Fluticasone furoate—Dizziness—Vemurafenib—melanoma	0.000651	0.00838	CcSEcCtD
Fluticasone furoate—Immune system disorder—Temozolomide—melanoma	0.00064	0.00823	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Temozolomide—melanoma	0.000639	0.00821	CcSEcCtD
Fluticasone furoate—Cough—Bleomycin—melanoma	0.000638	0.00821	CcSEcCtD
Fluticasone furoate—Rash—Vemurafenib—melanoma	0.000621	0.00799	CcSEcCtD
Fluticasone furoate—Dermatitis—Vemurafenib—melanoma	0.00062	0.00798	CcSEcCtD
Fluticasone furoate—Back pain—Carmustine—melanoma	0.000617	0.00794	CcSEcCtD
Fluticasone furoate—Headache—Vemurafenib—melanoma	0.000617	0.00794	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Docetaxel—melanoma	0.000609	0.00783	CcSEcCtD
Fluticasone furoate—Tremor—Carmustine—melanoma	0.000598	0.00769	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Bleomycin—melanoma	0.000597	0.00768	CcSEcCtD
Fluticasone furoate—Back pain—Temozolomide—melanoma	0.000597	0.00767	CcSEcCtD
Fluticasone furoate—Infection—Bleomycin—melanoma	0.000593	0.00763	CcSEcCtD
Fluticasone furoate—Agitation—Carmustine—melanoma	0.000587	0.00754	CcSEcCtD
Fluticasone furoate—Nausea—Vemurafenib—melanoma	0.000585	0.00753	CcSEcCtD
Fluticasone furoate—Tremor—Temozolomide—melanoma	0.000578	0.00743	CcSEcCtD
Fluticasone furoate—Agitation—Temozolomide—melanoma	0.000567	0.00729	CcSEcCtD
Fluticasone furoate—Angioedema—Temozolomide—melanoma	0.000564	0.00725	CcSEcCtD
Fluticasone furoate—Infection—Dactinomycin—melanoma	0.000553	0.00711	CcSEcCtD
Fluticasone furoate—Palpitations—Temozolomide—melanoma	0.000545	0.00701	CcSEcCtD
Fluticasone furoate—Cough—Temozolomide—melanoma	0.000538	0.00692	CcSEcCtD
Fluticasone furoate—Dyspnoea—Bleomycin—melanoma	0.000532	0.00684	CcSEcCtD
Fluticasone furoate—Infection—Carmustine—melanoma	0.000517	0.00666	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Docetaxel—melanoma	0.00051	0.00656	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Temozolomide—melanoma	0.000503	0.00647	CcSEcCtD
Fluticasone furoate—Infection—Temozolomide—melanoma	0.0005	0.00643	CcSEcCtD
Fluticasone furoate—Epistaxis—Docetaxel—melanoma	0.000495	0.00637	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Temozolomide—melanoma	0.000494	0.00635	CcSEcCtD
Fluticasone furoate—Urticaria—Bleomycin—melanoma	0.000474	0.0061	CcSEcCtD
Fluticasone furoate—Body temperature increased—Bleomycin—melanoma	0.000472	0.00607	CcSEcCtD
Fluticasone furoate—Pharyngitis—Docetaxel—melanoma	0.000468	0.00602	CcSEcCtD
Fluticasone furoate—Dyspnoea—Carmustine—melanoma	0.000464	0.00597	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Docetaxel—melanoma	0.000463	0.00596	CcSEcCtD
Fluticasone furoate—Visual impairment—Docetaxel—melanoma	0.000454	0.00584	CcSEcCtD
Fluticasone furoate—Dyspnoea—Temozolomide—melanoma	0.000449	0.00577	CcSEcCtD
Fluticasone furoate—Eye disorder—Docetaxel—melanoma	0.00044	0.00566	CcSEcCtD
Fluticasone furoate—Body temperature increased—Dactinomycin—melanoma	0.00044	0.00566	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Bleomycin—melanoma	0.00044	0.00566	CcSEcCtD
Fluticasone furoate—Immune system disorder—Docetaxel—melanoma	0.000426	0.00547	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Docetaxel—melanoma	0.000425	0.00546	CcSEcCtD
Fluticasone furoate—Body temperature increased—Carmustine—melanoma	0.000412	0.0053	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Dactinomycin—melanoma	0.00041	0.00527	CcSEcCtD
Fluticasone furoate—Urticaria—Temozolomide—melanoma	0.0004	0.00514	CcSEcCtD
Fluticasone furoate—Body temperature increased—Temozolomide—melanoma	0.000398	0.00512	CcSEcCtD
Fluticasone furoate—Back pain—Docetaxel—melanoma	0.000397	0.0051	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Carmustine—melanoma	0.000384	0.00494	CcSEcCtD
Fluticasone furoate—Diarrhoea—Dactinomycin—melanoma	0.000381	0.0049	CcSEcCtD
Fluticasone furoate—Rash—Bleomycin—melanoma	0.000376	0.00484	CcSEcCtD
Fluticasone furoate—Dermatitis—Bleomycin—melanoma	0.000376	0.00484	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP17A1—melanoma	0.000372	0.239	CrCbGaD
Fluticasone furoate—Hypersensitivity—Temozolomide—melanoma	0.000371	0.00477	CcSEcCtD
Fluticasone furoate—Palpitations—Docetaxel—melanoma	0.000362	0.00466	CcSEcCtD
Fluticasone furoate—Cough—Docetaxel—melanoma	0.000358	0.0046	CcSEcCtD
Fluticasone furoate—Diarrhoea—Carmustine—melanoma	0.000356	0.00458	CcSEcCtD
Fluticasone furoate—Nausea—Bleomycin—melanoma	0.000354	0.00456	CcSEcCtD
Fluticasone furoate—Rash—Dactinomycin—melanoma	0.000351	0.00451	CcSEcCtD
Fluticasone furoate—Dizziness—Carmustine—melanoma	0.000344	0.00443	CcSEcCtD
Fluticasone furoate—Diarrhoea—Temozolomide—melanoma	0.000344	0.00443	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Docetaxel—melanoma	0.000335	0.00431	CcSEcCtD
Fluticasone furoate—Dizziness—Temozolomide—melanoma	0.000333	0.00428	CcSEcCtD
Fluticasone furoate—Infection—Docetaxel—melanoma	0.000333	0.00428	CcSEcCtD
Fluticasone furoate—Nausea—Dactinomycin—melanoma	0.000331	0.00425	CcSEcCtD
Fluticasone furoate—Rash—Carmustine—melanoma	0.000328	0.00422	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Docetaxel—melanoma	0.000328	0.00422	CcSEcCtD
Fluticasone furoate—Dermatitis—Carmustine—melanoma	0.000328	0.00422	CcSEcCtD
Fluticasone furoate—Headache—Carmustine—melanoma	0.000326	0.0042	CcSEcCtD
Fluticasone furoate—Rash—Temozolomide—melanoma	0.000317	0.00408	CcSEcCtD
Fluticasone furoate—Dermatitis—Temozolomide—melanoma	0.000317	0.00408	CcSEcCtD
Fluticasone furoate—Headache—Temozolomide—melanoma	0.000315	0.00406	CcSEcCtD
Fluticasone furoate—Nausea—Carmustine—melanoma	0.000309	0.00398	CcSEcCtD
Fluticasone furoate—Dexamethasone—NOS2—melanoma	0.000303	0.195	CrCbGaD
Fluticasone furoate—Nausea—Temozolomide—melanoma	0.000299	0.00385	CcSEcCtD
Fluticasone furoate—Dyspnoea—Docetaxel—melanoma	0.000298	0.00384	CcSEcCtD
Fluticasone furoate—Body temperature increased—Docetaxel—melanoma	0.000265	0.0034	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP1B1—melanoma	0.000258	0.166	CrCbGaD
Fluticasone furoate—Hypersensitivity—Docetaxel—melanoma	0.000247	0.00317	CcSEcCtD
Fluticasone furoate—Diarrhoea—Docetaxel—melanoma	0.000229	0.00295	CcSEcCtD
Fluticasone furoate—Dizziness—Docetaxel—melanoma	0.000221	0.00285	CcSEcCtD
Fluticasone furoate—Rash—Docetaxel—melanoma	0.000211	0.00271	CcSEcCtD
Fluticasone furoate—Dermatitis—Docetaxel—melanoma	0.000211	0.00271	CcSEcCtD
Fluticasone furoate—Headache—Docetaxel—melanoma	0.00021	0.0027	CcSEcCtD
Fluticasone furoate—Nausea—Docetaxel—melanoma	0.000199	0.00256	CcSEcCtD
Fluticasone furoate—Triamcinolone—PTGS2—melanoma	0.000183	0.118	CrCbGaD
Fluticasone furoate—Betamethasone—PTGS2—melanoma	0.00015	0.0963	CrCbGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.000129	0.00456	CbGpPWpGaD
Fluticasone furoate—Betamethasone—ABCB1—melanoma	0.000127	0.0819	CrCbGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—APC—melanoma	0.000126	0.00447	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.000124	0.00441	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	0.000123	0.00437	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.000123	0.00437	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.000121	0.0043	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000119	0.00423	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.000118	0.00418	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.000117	0.00413	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000114	0.00403	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	0.000114	0.00402	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.000113	0.004	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—SOCS1—melanoma	0.000113	0.004	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000106	0.00375	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CTLA4—melanoma	0.000104	0.00369	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000102	0.00362	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000101	0.00357	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000101	0.00357	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	0.0001	0.00355	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—E2F1—melanoma	9.79e-05	0.00347	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IFNG—melanoma	9.76e-05	0.00346	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—CLNS1A—melanoma	9.73e-05	0.00345	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	9.62e-05	0.00341	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	9.52e-05	0.00337	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	9.46e-05	0.00335	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	9.24e-05	0.00327	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	9.12e-05	0.00323	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	9.08e-05	0.00322	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—FAS—melanoma	9.07e-05	0.00321	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	8.87e-05	0.00314	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	8.81e-05	0.00312	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	8.75e-05	0.0031	CbGpPWpGaD
Fluticasone furoate—Dexamethasone—PTGS2—melanoma	8.7e-05	0.056	CrCbGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL2—melanoma	8.68e-05	0.00307	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	8.6e-05	0.00305	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	8.57e-05	0.00304	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	8.56e-05	0.00303	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—HIF1A—melanoma	8.53e-05	0.00302	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—SKI—melanoma	8.52e-05	0.00302	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	8.48e-05	0.003	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	8.48e-05	0.003	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CCND1—melanoma	8.46e-05	0.003	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	8.38e-05	0.00297	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD86—melanoma	8.26e-05	0.00292	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	8.24e-05	0.00292	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MMP9—melanoma	8.21e-05	0.00291	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—PTEN—melanoma	8.16e-05	0.00289	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL10—melanoma	8.1e-05	0.00287	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	8e-05	0.00283	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	7.88e-05	0.00279	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL4—melanoma	7.88e-05	0.00279	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	7.84e-05	0.00278	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	7.78e-05	0.00275	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—PDGFRA—melanoma	7.76e-05	0.00275	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-B—melanoma	7.7e-05	0.00273	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	7.68e-05	0.00272	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	7.65e-05	0.00271	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	7.61e-05	0.00269	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	7.59e-05	0.00269	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—FASLG—melanoma	7.53e-05	0.00267	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	7.49e-05	0.00265	CbGpPWpGaD
Fluticasone furoate—Dexamethasone—ABCB1—melanoma	7.4e-05	0.0476	CrCbGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	7.37e-05	0.00261	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	7.28e-05	0.00258	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—FAS—melanoma	7.26e-05	0.00257	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—PPARG—melanoma	7.25e-05	0.00257	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	7.21e-05	0.00255	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	7.21e-05	0.00255	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	7.17e-05	0.00254	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	7.16e-05	0.00254	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-A—melanoma	7.14e-05	0.00253	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	7.08e-05	0.00251	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	7.02e-05	0.00249	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—RB1—melanoma	6.94e-05	0.00246	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IGF1—melanoma	6.88e-05	0.00244	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	6.82e-05	0.00242	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—melanoma	6.78e-05	0.0024	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NPPA—melanoma	6.67e-05	0.00236	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	6.52e-05	0.00231	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	6.34e-05	0.00224	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	6.31e-05	0.00223	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	6.15e-05	0.00218	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	6.04e-05	0.00214	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD80—melanoma	6.02e-05	0.00213	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	5.85e-05	0.00207	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CASP8—melanoma	5.6e-05	0.00198	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TP53—melanoma	5.57e-05	0.00197	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	5.36e-05	0.0019	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	5.16e-05	0.00183	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—CTNNB1—melanoma	5.1e-05	0.00181	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL6—melanoma	5.1e-05	0.00181	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—CDKN1A—melanoma	4.99e-05	0.00177	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	4.91e-05	0.00174	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	4.85e-05	0.00172	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	4.78e-05	0.00169	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IFNG—melanoma	4.76e-05	0.00169	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	4.69e-05	0.00166	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	4.58e-05	0.00162	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—MDM2—melanoma	4.5e-05	0.00159	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	4.49e-05	0.00159	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—STAT3—melanoma	4.45e-05	0.00158	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CXCL8—melanoma	4.43e-05	0.00157	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	4.41e-05	0.00156	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	4.28e-05	0.00152	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CASP3—melanoma	4.24e-05	0.0015	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2—melanoma	4.23e-05	0.0015	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	4.21e-05	0.00149	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	4.19e-05	0.00148	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—RPS3—melanoma	4.17e-05	0.00148	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	4.15e-05	0.00147	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	4.15e-05	0.00147	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—SNRPE—melanoma	4.1e-05	0.00145	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—SKI—melanoma	4.1e-05	0.00145	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.98e-05	0.00141	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	3.95e-05	0.0014	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.92e-05	0.00139	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	3.9e-05	0.00138	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	3.88e-05	0.00138	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	3.87e-05	0.00137	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TNF—melanoma	3.85e-05	0.00136	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	3.83e-05	0.00136	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—VDR—melanoma	3.8e-05	0.00135	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	3.79e-05	0.00134	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	3.72e-05	0.00132	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	3.65e-05	0.00129	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ACER3—melanoma	3.62e-05	0.00128	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—VEGFA—melanoma	3.6e-05	0.00127	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	3.58e-05	0.00127	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	3.51e-05	0.00124	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.35e-05	0.00119	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	3.34e-05	0.00118	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	3.33e-05	0.00118	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—UGT2B10—melanoma	3.31e-05	0.00117	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.3e-05	0.00117	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NPPA—melanoma	3.21e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	3.17e-05	0.00112	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	3.15e-05	0.00112	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IL6—melanoma	3.11e-05	0.0011	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TNF—melanoma	3.08e-05	0.00109	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HS3ST5—melanoma	3.08e-05	0.00109	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	2.97e-05	0.00105	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	2.93e-05	0.00104	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	2.81e-05	0.000994	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.76e-05	0.000979	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2.72e-05	0.000962	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	2.69e-05	0.000951	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	2.65e-05	0.000938	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—PPARG—melanoma	2.65e-05	0.000938	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	2.63e-05	0.00093	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.5e-05	0.000885	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.37e-05	0.00084	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HDAC2—melanoma	2.35e-05	0.000831	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.34e-05	0.000828	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PLCB4—melanoma	2.34e-05	0.000827	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.3e-05	0.000816	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.25e-05	0.000798	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ACER3—melanoma	2.23e-05	0.000791	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SLC6A11—melanoma	2.2e-05	0.000778	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIP4K2A—melanoma	2.2e-05	0.000778	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.14e-05	0.000759	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—MTAP—melanoma	2.14e-05	0.000756	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.13e-05	0.000756	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.09e-05	0.000741	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—UGT2B10—melanoma	2.04e-05	0.000723	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.04e-05	0.000721	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.02e-05	0.000714	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.97e-05	0.000697	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.96e-05	0.000696	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.96e-05	0.000692	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—LUM—melanoma	1.9e-05	0.000674	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PHGDH—melanoma	1.9e-05	0.000674	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HS3ST5—melanoma	1.9e-05	0.000672	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—CDKN2B—melanoma	1.88e-05	0.000664	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HPSE—melanoma	1.87e-05	0.000661	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CUBN—melanoma	1.83e-05	0.000649	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—VDR—melanoma	1.83e-05	0.000648	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.77e-05	0.000628	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SDHD—melanoma	1.77e-05	0.000627	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CSPG4—melanoma	1.77e-05	0.000627	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—BSG—melanoma	1.77e-05	0.000627	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GPAM—melanoma	1.71e-05	0.000607	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PRKCA—melanoma	1.69e-05	0.000597	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.68e-05	0.000595	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ERCC2—melanoma	1.67e-05	0.000592	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.63e-05	0.000578	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.6e-05	0.000566	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.6e-05	0.000566	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.52e-05	0.000539	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—melanoma	1.51e-05	0.000535	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.51e-05	0.000534	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PLA2G6—melanoma	1.46e-05	0.000516	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PLCB4—melanoma	1.44e-05	0.000509	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.39e-05	0.000491	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SLC6A11—melanoma	1.35e-05	0.000479	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIP4K2A—melanoma	1.35e-05	0.000479	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NOTCH1—melanoma	1.35e-05	0.000478	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.34e-05	0.000475	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—MTAP—melanoma	1.32e-05	0.000466	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—VCAN—melanoma	1.31e-05	0.000464	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PPARG—melanoma	1.28e-05	0.000452	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PHGDH—melanoma	1.17e-05	0.000415	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—LUM—melanoma	1.17e-05	0.000415	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HPSE—melanoma	1.15e-05	0.000407	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.13e-05	0.000401	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CUBN—melanoma	1.13e-05	0.0004	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP17A1—melanoma	1.1e-05	0.000391	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SDHD—melanoma	1.09e-05	0.000386	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—BSG—melanoma	1.09e-05	0.000386	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CSPG4—melanoma	1.09e-05	0.000386	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GPAM—melanoma	1.06e-05	0.000374	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GNA11—melanoma	1.04e-05	0.000369	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.02e-05	0.000362	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—FASN—melanoma	1.02e-05	0.000361	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SLC5A5—melanoma	1e-05	0.000356	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GNAQ—melanoma	9.7e-06	0.000343	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CD44—melanoma	9.7e-06	0.000343	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP1B1—melanoma	9.3e-06	0.000329	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PLA2G6—melanoma	8.98e-06	0.000318	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—VCAN—melanoma	8.07e-06	0.000286	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MAPK3—melanoma	7.47e-06	0.000265	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—melanoma	7.27e-06	0.000257	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PRKCA—melanoma	7.05e-06	0.00025	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ERCC2—melanoma	6.99e-06	0.000247	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP17A1—melanoma	6.8e-06	0.000241	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GNA11—melanoma	6.43e-06	0.000228	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—FASN—melanoma	6.29e-06	0.000223	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SLC5A5—melanoma	6.19e-06	0.000219	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CD44—melanoma	5.97e-06	0.000212	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GNAQ—melanoma	5.97e-06	0.000212	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP1B1—melanoma	5.73e-06	0.000203	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CG—melanoma	5.52e-06	0.000195	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PPARG—melanoma	5.33e-06	0.000189	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—AKT1—melanoma	5.04e-06	0.000179	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CD—melanoma	4.85e-06	0.000172	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALB—melanoma	4.79e-06	0.00017	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ABCB1—melanoma	4.72e-06	0.000167	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PRKCA—melanoma	4.34e-06	0.000154	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ERCC2—melanoma	4.31e-06	0.000152	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CB—melanoma	4.23e-06	0.00015	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTGS2—melanoma	4.19e-06	0.000148	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTEN—melanoma	3.65e-06	0.000129	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CG—melanoma	3.4e-06	0.00012	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PPARG—melanoma	3.28e-06	0.000116	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CD—melanoma	2.99e-06	0.000106	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALB—melanoma	2.95e-06	0.000104	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CB—melanoma	2.61e-06	9.23e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTGS2—melanoma	2.58e-06	9.14e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CA—melanoma	2.58e-06	9.13e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTEN—melanoma	2.25e-06	7.97e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—AKT1—melanoma	2.11e-06	7.46e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CA—melanoma	1.59e-06	5.62e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—AKT1—melanoma	1.3e-06	4.59e-05	CbGpPWpGaD
